Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Triac trial in Allan-Herndon-Dudley syndrome
NL-OMON44458Phase 2Active, not recruiting
- Sponsor
- Erasmus MC
- Start
- Oct 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of tiratricol in Allan-Herndon-Dudley syndrome (AHDS), sponsored by Erasmus MC. Primary endpoint: Serum thyroid hormone parameters. Started Oct 2014; status: active, not recruiting.
02
Drugs
tiratricol
03
Conditions
Allan-Herndon-Dudley syndrome (AHDS)
Beyond the preview
Go deeper on NL-OMON44458.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON44458.